Yi‐He Ling
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 9
- DNA Repair Mechanisms 6
- Cell death mechanisms and regulation 4
- DNA and Nucleic Acid Chemistry 4
- Oncology 18
- HER2/EGFR in Cancer Research 5
- Drug Transport and Resistance Mechanisms 4
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Román Pérez-Soler (22 shared papers)Yiyu Zou (10 shared papers)Leonard Liebes (1 shared paper)Carmen Tornos (2 shared papers)Tianhong Li (2 shared papers)I. David Goldman (1 shared paper)James F. Holland (3 shared papers)Waldemar Priebe (6 shared papers)
- Journals
- Cancer Research (5 papers)International Journal of Cancer (5 papers)Molecular Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesChinaFinland
In The Last Decade
Yi‐He Ling
36 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 96
- Oncology 754
- Toxicology 64
- Molecular Biology 1.2k
- Cancer Research 201
- Cell Biology 201
Countries citing papers authored by Yi‐He Ling
This map shows the geographic impact of Yi‐He Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐He Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐He Ling more than expected).
Fields of papers citing papers by Yi‐He Ling
This network shows the impact of papers produced by Yi‐He Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐He Ling. The network helps show where Yi‐He Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi‐He Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 378 | |
| 2 | 2008 | 373 | |
| 3 | 1998 | 209 | |
| 4 | 2007 | 175 | |
| 5 | 2002 | 135 | |
| 6 | 1997 | 133 | |
| 7 | 2013 | 104 | |
| 8 | 2006 | 97 | |
| 9 | 1998 | 90 | |
| 10 | 2005 | 74 | |
| 11 | 2009 | 52 | |
| 12 | 2000 | 46 | |
| 13 | 2001 | 39 | |
| 14 | 2009 | 32 | |
| 15 | 1995 | 31 | |
| 16 | Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. | 2002 | 24 |
| 17 | 1999 | 21 | |
| 18 | 2007 | 20 | |
| 19 | 1993 | 19 | |
| 20 | 2001 | 18 |
About Yi‐He Ling
Yi‐He Ling is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Toxicology and Biomaterials, having authored 37 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Lung Cancer Treatments and Mutations (7 papers), DNA Repair Mechanisms (6 papers), HER2/EGFR in Cancer Research (5 papers), Cell death mechanisms and regulation (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Oncology (754 citations), Toxicology (64 citations), Molecular Biology (1.2k citations), Cancer Research (201 citations) and Cell Biology (201 citations). Yi‐He Ling has collaborated with scholars based in United States, China and Finland. Frequent co-authors include Román Pérez-Soler, Yiyu Zou, Leonard Liebes, Carmen Tornos, Tianhong Li, I. David Goldman, James F. Holland, Waldemar Priebe, John M. Mariadason and Diego Arango. Their work appears in journals such as Cancer Research, International Journal of Cancer, Molecular Pharmacology, Cancer Chemotherapy and Pharmacology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.